HCC |
Hepatocellular carcinoma |
OS |
Overall survival |
HSPs |
Heat shock proteins |
HSP70 |
Heat shock protein 70 |
DFS |
Disease-free survival |
eIF4G |
Eukaryotic translation initiation factor 4G |
eIF4F |
Eukaryotic translation initiation factor 4F |
eIF4A |
Eukaryotic translation initiation factor 4A |
eIF4E |
Eukaryotic translation initiation factor 4E |
4EBP1 |
Eukaryotic translation initiation factor 4E binding protein 1 |
IRES |
internal ribosomal entry site |
H&E |
hematoxylin and eosin stain |
AFP |
alpha-fetoprotein |
NASH |
nonal- coholic steatohepatitis |
ECGO PS |
Eastern Cooperative Oncology Group Performance Status |
BCLC |
Barcelona clinic liver cancer |
TNM |
Tumor, Node, Metastasis |
PFS |
Progression-free survival |
Co-IP |
Co-Immunoprecipitation |
CoCl2
|
Cobalt chloride |
IC50 |
Proximity Ligation Assay |
Apaf-1 |
apoptosis protease activating factor 1 |
Ask-1 |
apoptosis signal-regulated kinase 1 |
MAPK |
mitogen-activated protein kinase |
mHSP70 |
membrane HSP70 |
NSCLC |
non-small cell lung carcinoma |
RCT |
Radiochemotherapy |
IL-2 |
Interleukin-2 |
IL-5 |
Interleukin-5 |
ERK |
extracellular-signal-regulated kinase |
IF |
Immunofluorescence |
shRNA |
Short hairpin RNA |
siRNA |
Small interfering RNA |